Vaginal cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 16: | Line 16: | ||
*1 in 100,000 women will be diagnosed with in situ or invasive vaginal cancer<ref name="pmid19384118">{{cite journal |vauthors=Shah CA, Goff BA, Lowe K, Peters WA, Li CI |title=Factors affecting risk of mortality in women with vaginal cancer |journal=Obstet Gynecol |volume=113 |issue=5 |pages=1038–45 |date=May 2009 |pmid=19384118 |pmc=2746762 |doi=10.1097/AOG.0b013e31819fe844 |url=}}</ref>. | *1 in 100,000 women will be diagnosed with in situ or invasive vaginal cancer<ref name="pmid19384118">{{cite journal |vauthors=Shah CA, Goff BA, Lowe K, Peters WA, Li CI |title=Factors affecting risk of mortality in women with vaginal cancer |journal=Obstet Gynecol |volume=113 |issue=5 |pages=1038–45 |date=May 2009 |pmid=19384118 |pmc=2746762 |doi=10.1097/AOG.0b013e31819fe844 |url=}}</ref>. | ||
*Most cases of vaginal cancer are likely mediated by human papillomavirus (HPV) infection, as with cervical cancer | *Most cases of vaginal cancer are likely mediated by human papillomavirus (HPV) infection, as with cervical cancer<ref name="pmid25155250">{{cite journal |vauthors=Alemany L, Saunier M, Tinoco L, Quirós B, Alvarado-Cabrero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J, Salmerón J, Bergeron C, Petry KU, Guimerà N, Clavero O, Murillo R, Clavel C, Wain V, Geraets DT, Jach R, Cross P, Carrilho C, Molina C, Shin HR, Mandys V, Nowakowski AM, Vidal A, Lombardi L, Kitchener H, Sica AR, Magaña-León C, Pawlita M, Quint W, Bravo IG, Muñoz N, de Sanjosé S, Bosch FX |title=Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples |journal=Eur. J. Cancer |volume=50 |issue=16 |pages=2846–54 |date=November 2014 |pmid=25155250 |doi=10.1016/j.ejca.2014.07.018 |url=}}</ref>. | ||
*Vaginal cancer has the same risk factors as cervical neoplasia: multiple lifetime sexual partners, early age at first intercourse, and being a current smoker [9,10]. | *Vaginal cancer has the same risk factors as cervical neoplasia: multiple lifetime sexual partners, early age at first intercourse, and being a current smoker [9,10]. | ||
*There is evidence that some high-grade vulvar and vaginal intraepithelial neoplasia are monoclonal lesions derived from high-grade or malignant cervical disease [11]. | *There is evidence that some high-grade vulvar and vaginal intraepithelial neoplasia are monoclonal lesions derived from high-grade or malignant cervical disease [11]. | ||
Revision as of 16:55, 21 January 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Vaginal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vaginal cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Vaginal cancer epidemiology and demographics |
|
Risk calculators and risk factors for Vaginal cancer epidemiology and demographics |
Overview
In 2015, the incidence of vaginal cancer is approximately 2-3 per 100,000 individuals with a death number of 910.
Epidemiology and Demographics
- Carcinomas of the vagina are uncommon tumors comprising about 1% of the cancers that arise in the female genital system[1].
- Estimated new cases and deaths from vaginal (and other female genital) cancer in the United States in 2015:
- New cases: 4,070.
- Deaths: 910.
- Estimated new cases and deaths from vaginal (and other female genital) cancer in the United States in 2008:
- New cases: 2,210.
- Deaths: 760.
- 1 in 100,000 women will be diagnosed with in situ or invasive vaginal cancer[2].
- Most cases of vaginal cancer are likely mediated by human papillomavirus (HPV) infection, as with cervical cancer[3].
- Vaginal cancer has the same risk factors as cervical neoplasia: multiple lifetime sexual partners, early age at first intercourse, and being a current smoker [9,10].
- There is evidence that some high-grade vulvar and vaginal intraepithelial neoplasia are monoclonal lesions derived from high-grade or malignant cervical disease [11].
References
- ↑ Gadducci A, Fabrini MG, Lanfredini N, Sergiampietri C (March 2015). "Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors". Crit. Rev. Oncol. Hematol. 93 (3): 211–24. doi:10.1016/j.critrevonc.2014.09.002. PMID 25476235.
- ↑ Shah CA, Goff BA, Lowe K, Peters WA, Li CI (May 2009). "Factors affecting risk of mortality in women with vaginal cancer". Obstet Gynecol. 113 (5): 1038–45. doi:10.1097/AOG.0b013e31819fe844. PMC 2746762. PMID 19384118.
- ↑ Alemany L, Saunier M, Tinoco L, Quirós B, Alvarado-Cabrero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J, Salmerón J, Bergeron C, Petry KU, Guimerà N, Clavero O, Murillo R, Clavel C, Wain V, Geraets DT, Jach R, Cross P, Carrilho C, Molina C, Shin HR, Mandys V, Nowakowski AM, Vidal A, Lombardi L, Kitchener H, Sica AR, Magaña-León C, Pawlita M, Quint W, Bravo IG, Muñoz N, de Sanjosé S, Bosch FX (November 2014). "Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples". Eur. J. Cancer. 50 (16): 2846–54. doi:10.1016/j.ejca.2014.07.018. PMID 25155250.